Sandler Capital Management’s Medtronic MDT Stock Holding History

Sandler Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-57,000	Closed	-$6.19M	–	100
2019 Q3	$6.19M	Buy	+57,000	New	+$5.95M	0.54%	67
2016 Q3	–	Sell	-5,950	Closed	-$516K	–	127
2016 Q2	$516K	Buy	5,950 +1,150	+24%	+$93K	0.07%	97
2016 Q1	$360K	Sell	4,800 -107,200	-96%	-$8.07M	0.04%	107
2015 Q4	$8.62M	Buy	112,000 +21,000	+23%	+$1.58M	0.82%	46
2015 Q3	$6.09M	Sell	91,000 -37,984	-29%	-$2.8M	0.71%	45
2015 Q2	$9.56M	Sell	128,984 -9,056	-7%	-$692K	0.85%	36
2015 Q1	$10.8M	Buy	138,040 +42,840	+45%	+$3.25M	0.66%	44
2014 Q4	$6.87M	Sell	95,200 -124,800	-57%	-$8.67M	0.36%	103
2014 Q3	$13.6M	Buy	+220,000	New	+$14M	0.65%	59

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sandler Capital Management's MDT Position: Q4 2019 in Review

Sandler Capital Management sold out of Medtronic (MDT) in Q4 2019, closing a stake of 57,000 shares — an estimated $6.19M sold.

Sandler Capital Management first reported a position in MDT in Q3 2014 and held it in 9 quarters. The position peaked at $13.6M in Q3 2014. 1,820 funds tracked by Wall St. Rank hold MDT as of Q4 2019.

Sandler Capital Management reported no remaining Medtronic position as of Q4 2019 after selling out during the quarter.
Sandler Capital Management sold 57,000 Medtronic shares in Q4 2019, an estimated $6.19M.
Sandler Capital Management first reported a position in Medtronic in Q3 2014 and held it in 9 quarters.
Sandler Capital Management's Medtronic position peaked at $13.6M in Q3 2014.
1,820 funds tracked by Wall St. Rank held Medtronic as of Q4 2019.

Based on Sandler Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.